BioCentury
ARTICLE | Distillery Therapeutics

Combined blockade of GD2 and CD47 for cancer

February 11, 2022 9:02 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer; bone cancer; lung cancer...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Stanford University

BCIQ Target Profiles

CD47

Ganglioside GD2 (GD2)